{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:08:32Z","timestamp":1775887712723,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To explore the association between PRIM2 expression and prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) from multiclinic centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>Samples from PDAC patients were collected and processed to tissue microarray (TMA). PRIM2 expression was detected by immunohistochemistry (IHC) of in 127 enrolled PDAC patients who underwent surgical resection from January 2012 to December 2018, were with complete follow-up, and were enrolled and grouped by PRIM2 stain level into 2 groups. The expression differences, the association to clinicopathologic features, and the survival were evaluated by the groups. Data of RNA\/protein expression and clinical features from public databases were used for validation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>PRIM2 was highly expressed in PDAC patients and associated with poor prognosis in patients with PDAC. Association was found between increased PRIM2 levels and pathology grade (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.050). Moreover, in multivariate analysis of survival, the highly expression of PRIM2 was identified as an independent risk factor for poor survival (HR, 1.78; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.031). Analysis on public databases validated above results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>High expression of PRIM2 was associated with poor prognosis in PDAC patients, and PRIM2 could be used as an independent risk indicator.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002387","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T19:01:06Z","timestamp":1726081266000},"page":"e11-e17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1097","volume":"54","author":[{"given":"Jingyang","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiang","family":"Guo","sequence":"additional","affiliation":[{"name":"Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renpei","family":"Xia","sequence":"additional","affiliation":[{"name":"Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"bib1-20241211","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"bib2-20241211","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","year":"2021","journal-title":"JAMA"},{"key":"bib3-20241211","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/cancers14143370","article-title":"PRIM2 promotes cell cycle and tumor progression in p53-mutant lung cancer","volume":"14","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib4-20241211","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/ijc.33702","article-title":"Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival","volume":"149","year":"2021","journal-title":"Int J Cancer"},{"key":"bib5-20241211","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2019.06.030","article-title":"Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer","volume":"76","year":"2019","journal-title":"Eur Urol"},{"key":"bib6-20241211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"bib7-20241211","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","year":"2021","journal-title":"Cell"},{"key":"bib8-20241211","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12916-018-1215-3","article-title":"Pancreatic cancer: challenges and opportunities","volume":"16","year":"2018","journal-title":"BMC Med"},{"key":"bib9-20241211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13543784.2019.1557145","article-title":"Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)","volume":"28","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"bib10-20241211","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12935-022-02640-9","article-title":"Advances in biomarkers and techniques for pancreatic cancer diagnosis","volume":"22","year":"2022","journal-title":"Cancer Cell Int"},{"key":"bib11-20241211","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3892\/ijo.2014.2510","article-title":"Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer","volume":"45","year":"2014","journal-title":"Int J Oncol"},{"key":"bib12-20241211","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10799893.2021.1936554","article-title":"Curcumin restrains hepatocellular carcinoma progression depending on the regulation of the circ_0078710\/miR-378b\/PRIM2 axis","volume":"42","year":"2022","journal-title":"J Recept Signal Transduct Res"},{"key":"bib13-20241211","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4161\/cc.10.6.15010","article-title":"Crystal structure of the C-terminal domain of human DNA primase large subunit: implications for the mechanism of the primase-polymerase \u03b1 switch","volume":"10","year":"2011","journal-title":"Cell Cycle"},{"key":"bib14-20241211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.leu.2404034","article-title":"Assessment of F-MuLV\u2013induced tumorigenesis reveals new candidate tumor genes including Pecam1, St7, and Prim2","volume":"20","year":"2006","journal-title":"Leukemia"},{"key":"bib15-20241211","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/genes12091448","article-title":"Whole-genome profiles of Malay colorectal cancer patients with intact MMR proteins","volume":"12","year":"2021","journal-title":"Genes (Basel)"},{"key":"bib16-20241211","doi-asserted-by":"crossref","first-page":"103510","DOI":"10.1016\/j.ebiom.2021.103510","article-title":"Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma","volume":"70","year":"2021","journal-title":"EBioMedicine"},{"key":"bib17-20241211","first-page":"8762717","article-title":"Targets and potential mechanism of Scutellaria baicalensis in treatment of primary hepatocellular carcinoma based on bioinformatics analysis","volume":"2022","year":"2022","journal-title":"J Oncol"},{"key":"bib18-20241211","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.2147\/OTT.S248492","article-title":"Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 axis","volume":"13","year":"2020","journal-title":"Onco Targets Ther"},{"key":"bib19-20241211","doi-asserted-by":"crossref","first-page":"691161","DOI":"10.3389\/fcell.2021.691161","article-title":"Identification of novel metabolism-associated subtypes for pancreatic cancer to establish an eighteen-gene risk prediction model","volume":"9","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"bib20-20241211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tcb.2019.12.001","article-title":"Protecting the aging genome","volume":"30","year":"2020","journal-title":"Trends Cell Biol"},{"key":"bib21-20241211","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21873\/cgp.20440","article-title":"PRIM2: a marker of MYC-driven hyper-proliferation, disease progression, tumor aggressiveness and poor survival in glioma patients","volume":"21","year":"2024","journal-title":"Cancer Genomics Proteomics"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T19:02:43Z","timestamp":1733943763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002387","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}